BETHANIE SORENSEN: Open Payments
NPI 1396747044 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 19 payments from 8 companies in 2025. Trend: 2023 $690 · 2024 $482 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $48 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: AVEIR, LEQVIO, LifeVest, OPSUMIT, Wegovy, Kerendia, FARXIGA, NEXLETOL.
Industry payments across AZ — which companies pay providers there.
